Alnylam Pharmaceuticals shares owned by ClearBridge Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by ClearBridge Advisors
from 13F filings
Historical chart of ClearBridge Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals by ClearBridge Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $284M | 622k | 456.00 |
| 2025-06-30 | $182M | 557k | 326.09 |
| 2025-03-31 | $2.1M | 7.8k | 270.03 |
| 2023-06-30 | $16M | 83k | 189.94 |
| 2023-03-31 | $15M | 76k | 200.32 |
| 2022-12-31 | $14M | 57k | 237.65 |
| 2020-06-30 | $54k | 365 | 147.95 |
| 2020-03-31 | $40k | 365 | 109.59 |
| 2019-12-31 | $44k | 377 | 116.71 |
| 2019-09-30 | $30k | 377 | 79.58 |
| 2019-06-30 | $27k | 377 | 71.62 |
| 2019-03-31 | $35k | 377 | 92.84 |
| 2018-12-31 | $27k | 377 | 71.62 |
| 2018-09-30 | $33k | 377 | 87.53 |
| 2018-06-30 | $37k | 377 | 98.14 |
| 2018-03-31 | $253k | 2.1k | 119.23 |
| 2017-12-31 | $320k | 2.5k | 127.19 |
| 2017-09-30 | $472k | 4.0k | 117.47 |
| 2017-06-30 | $338k | 4.2k | 79.77 |
| 2017-03-31 | $57k | 1.1k | 51.68 |
| 2016-12-31 | $41k | 1.1k | 37.17 |
| 2016-09-30 | $74k | 1.1k | 68.20 |
| 2016-06-30 | $33k | 594 | 55.56 |